An electrochemical biosensor test strip with four new features. The test strip includes an indentation for tactile feel as to the location of the strips sample application port. The sample application port leads to a capillary test chamber, which includes a test reagent. The wet reagent includes from about 0.2% by weight to about 2% by weight polyethylene oxide from about 100 kilodaltons to about 900 kilodaltons mean molecular weight, which makes the dried reagent more hydrophilic and sturdier to strip processing steps, such as mechanical punching, and to mechanical manipulation by the test strip user. The roof of the capillary test chamber includes a transparent or translucent window which operates as a “fill to here” line, thereby identifying when enough test sample (a liquid sample, such as blood) has been added to the test chamber to accurately perform a test. The test strip may further include a notch located at the sample application port. The notch reduces a phenomenon called “dose hesitation”.
|
0. 33. An electrochemical test strip for conducting testing for the concentration of glucose in a blood sample, comprising:
a strip body including an edge surface extending about the perimeter of said strip body, said strip body defining a capillary channel and a vent in fluid communication with the capillary channel, said strip body comprising a sample application port open at a location along the edge surface, the capillary channel having opposed sides extending from the sample application port to at least the vent;
at least working and counter electrodes spaced from each other and positioned within the capillary channel at a location spaced from the edge surface;
a test reagent adjacent at least the working electrode; and
visualization means associated with the capillary channel and including a solid, transparent or translucent viewing material extending from at least adjacent the sample application port and overlying at least a portion of the capillary channel including said working electrode and at least a portion of said counter electrode,
said strip body having opaque portions which, in combination with said viewing material, define a window effective for providing visual confirmation that a sufficient area of the working and counter electrodes is covered with sample to have a minimum sample amount for said test strip.
0. 43. An electrochemical test strip for conducting testing for the concentration of glucose in a blood sample, comprising:
a strip body including an edge surface extending about the perimeter of said strip body, said strip body defining a capillary channel and a vent in fluid communication with the capillary channel, said strip body comprising a sample application port open at a location along the perimetric edge surface, the capillary channel extending from the sample application port to at least the vent, said strip body further defining a test area along the capillary channel between the sample application port and the vent; at least working and counter electrodes spaced from each other and positioned within the test area of the capillary channel at a location spaced from the perimetric edge surface;
a test reagent received within the test area of the capillary channel and adjacent at least the working electrode;
said strip body including a solid, transparent or translucent viewing material overlying at least a portion of the capillary channel, including from a portion thereof at or generally adjacent the sample application port continuously up to and including said working electrode and at least a portion of said counter electrode, the viewing material permitting visualization of the blood sample as it moves through the capillary channel to the test area;
said strip body further including opaque portions defining a fill area viewable through the viewing material, the fill area extending from adjacent the sample application port continuously up to the working electrode and at least a part of the counter electrode and limited to an area of the capillary channel needed to be filled to conduct an accurate test;
wherein observation through the viewing material of the blood sample within the capillary channel up to said electrodes comprises confirmation of sufficient blood sample being introduced into the capillary channel to conduct a test.
0. 1. A test strip, having an indentation along an edge for tactile identification of a sample application port, said test strip comprising:
a first insulating substrate having first and second surfaces, an indentation along an edge and a vent hole;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces, an indentation along an edge, and first and second openings, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the first opening exposing a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the second opening being located along said edge and exposing a different portion of the conductive tracks and the vent hole;
a test reagent overlaying at least a portion of the conductive tracks exposed by the second opening; and
a roof having first and second surfaces and an indentation along an edge, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so that the second surface of the roof and the surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate, wherein the second opening in the second insulating substrate and the indentations in the first insulating substrate, the second insulating substrate, and the roof are aligned to thereby provide for tactile identification of the sample application port.
0. 2. The test strip of
0. 3. The test strip of
reaction components appropriate for performing a test and from about 1.75% by weight to about 17.5% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the reagent will redissolve or resuspend upon addition of an aqueous test sample to the reagent.
0. 4. The test strip of
wherein the test reagent may be applied to the test strip in a wet form, may be subsequently dried, and then redissolved or resuspended upon addition of an aqueous test sample to the dried reagent.
0. 5. The test strip of
0. 6. The test strip of
0. 7. The test strip of
0. 8. The test strip of
reaction components appropriate for performing a test and from about 1.75% by weight to about 17.5% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the reagent will redissolve or resuspend upon addition of an aqueous test sample to the reagent.
0. 9. The test strip of
wherein the test reagent may be applied to the test strip in a wet form, may be subsequently dried, and then redissolved or resuspended upon addition of an aqueous test sample to the dried reagent.
0. 10. The test strip of
0. 11. The test strip of
a first notch along the indentation in the first insulating substrate, and a notch along the indentation in the roof, both first and second notches being positioned so that they overlay one another.
0. 12. The test strip of
0. 13. The test strip of
reaction components appropriate for performing a test and from about 1.75% by weight to about 17.5% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the reagent will redissolve or resuspend upon addition of an aqueous test sample to the reagent.
0. 14. The test strip of
wherein the test reagent may be applied to the test strip in a wet form, may be subsequently dried, and then redissolved or resuspended upon addition of an aqueous test sample to the dried reagent.
0. 15. The test strip of
0. 16. The test strip of
0. 17. The test strip of
0. 18. The test strip of
wherein the test reagent may be applied to the test strip in a wet form, may be subsequently dried, and then redissolved or resuspended upon addition of an aqueous test sample to the dried reagent.
0. 19. The test strip of
0. 20. The test strip of
0. 21. The test strip of
0. 22. The test strip of
reaction components appropriate for performing a test and from about 1.75% by weight to about 17.5% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the reagent will redissolve or resuspend upon addition of an aqueous test sample to the reagent.
0. 23. The test strip of
0. 24. The test strip of
0. 25. A test strip comprising:
a first insulating substrate having first and second surfaces, a notch along an edge, and a vent hole;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces and first and second openings, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the first opening exposing a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the second opening being located along an edge of the second insulating substrate and exposing a different portion of the conductive tracks, the notch in the first insulating substrate, and the vent hole;
a test reagent overlaying at least a portion of the conductive tracks exposed by the second opening; and
a roof having first and second surfaces and a notch along an edge, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so that 1) the second surface of the roof and the first surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate, and 2) the notch in the roof overlays the notch in the first insulating substrate;
whereby the notch in the roof and the notch in the first insulating substrate will cause a liquid aqueous sample, when touched to the sample application port, to flow into the capillary chamber without significant hesitation.
0. 26. A test strip, comprising:
a first insulating substrate having first and second surfaces and a vent hole;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces and first and second openings, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the first opening exposing a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the second opening being located along an edge of the second insulating substrate and exposing a different portion of the conductive tracks and the vent hole;
a test reagent overlaying at least a portion of the conductive tracks exposed by the second opening; and
a roof having first and second surfaces and a solid transparent or translucent window, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so that it overlays the second opening of the second insulating substrate and so that the second surface of the roof and the first surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate, and the transparent or translucent window being dimensioned and positioned so that the window extends from the sample application port, and overlays the entire width of one of the electrically conductive tracks and at least about ten percent of the width of the other electrically conductive track.
0. 27. A test strip, having an indentation along an edge for tactile identification of a sample application port, said test strip comprising:
a first insulating substrate having first and second surfaces and an indentation along an edge;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces, an indentation along an edge and an opening, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the second insulating substrate configured to expose a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the opening being located along said edge and exposing a different portion of the conductive tracks;
a test reagent overlaying at least a portion of the conductive tracks exposed by the opening;
a roof having first and second surfaces and an indentation along an edge, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so as to overlay the opening and so that the second surface of the roof and the first surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate; and
a vent hole communicating with the capillary fill chamber;
wherein the opening in the second insulating substrate and the indentations in the first insulating substrate, the second insulating substrate, and the roof are aligned to thereby provide for tactile identification of the sample application port.
0. 28. The test strip of
0. 29. The test strip of
0. 30. The test strip of
0. 31. A test strip comprising:
a first insulating substrate having first and second surfaces and a notch along an edge;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces and an opening, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the second insulating substrate configured to expose a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the opening being located along an edge of the second insulating substrate and exposing a different portion of the conductive tracks, aid overlaying the notch in the first insulating substrate;
a test reagent overlaying at least a portion of the conductive tracks exposed by the opening;
a roof having first and second surfaces and a notch along an edge, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so that 1) the second surface of the roof and the first surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate, and 2) the notch in the roof overlays the notch in the first insulating substrate; and
a vent hole communicating with the capillary fill chamber;
whereby the notch in the roof and the notch in the first insulating substrate will cause a liquid aqueous sample, when touched to the sample application port, to flow into the capillary chamber without significant hesitation.
0. 32. A test strip comprising:
a first insulating substrate having first and second surfaces;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces and an opening, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the second insulating substrate configured to expose a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the opening being located along an edge of the second insulating substrate and exposing a different portion of the conductive tracks;
a test reagent overlaying at least a portion of the conductive tracks exposed by the opening;
a roof having first and second surfaces and a solid transparent or translucent window, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so that it overlays the opening of the second insulating substrate and so that the second surface of the roof and the first surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate, and the transparent or translucent window being dimensioned and positioned so that the window extends from the sample application port, and overlays the entire width of one of the electrically conductive tracks and at least about ten percent of the width of the other electrically conductive track; and
a vent hole communicating with the capillary fill chamber.
0. 34. The test strip of claim 33 in which the opposed sides of the capillary channel are parallel and extend in a straight line from the sample application port, and orthogonal to the perimetric edge surface, to at least one of the electrodes.
0. 35. The test strip of claim 34 in which the opaque portions are spaced apart to reveal greater than about 75% of the width of the capillary channel.
0. 36. The test strip of claim 35 in which the opaque portions are aligned with the opposed sides of the capillary channel.
0. 37. The test strip of claim 33 in which said strip body includes a first substrate, a second substrate and a roof, the second substrate being positioned intermediate the first substrate and the roof and including an opening, the opening of the second substrate together with the first substrate and the roof defining the capillary channel.
0. 38. The test strip of claim 37 in which said test strip includes conductive tracks connected with said working and counter electrodes, the first substrate having first and second surfaces, the working and counter electrodes being affixed to the first surface of the first substrate, the second substrate having first and second surfaces and an opening, the second surface of the second substrate being affixed to the first surface of the first substrate, the second substrate configured to expose a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the opening being located along a perimetric edge surface of the second substrate and exposing said electrodes, and a roof having first and second surfaces and including a solid, transparent or translucent, viewing material, the second surface of the roof being affixed to the first surface of the second substrate and positioned so that it overlays the opening of the second substrate and so that the second surface of the roof and the first surface of the first substrate form opposing walls of the capillary channel, the transparent or translucent viewing material extending from at least adjacent to the sample application port and overlying the entire width of one of the electrodes and at least about ten percent of the width of the other electrode.
0. 39. The test strip of claim 37 in which the second substrate defines the opposed sides of the capillary channel, the sides being parallel and extending in a straight line from the sample application port, and orthogonal to the perimetric edge surface, to at least one of the electrodes.
0. 40. The test strip of claim 39 in which the opaque portions are spaced apart to reveal greater than about 75% of the width of the capillary channel.
0. 41. The test strip of claim 40 in which the opaque portions are aligned with the opposed sides of the capillary channel.
0. 42. The test strip of claim 41 in which the opaque portions are defined by the roof.
0. 44. The test strip of claim 43 in which the opaque portions are sized and dimensioned such that the blood sample is required to fill up to the electrodes the portion of the capillary channel viewable through the viewing material and between the opaque portions in order to have a sufficient amount of blood sample to conduct a test.
0. 45. The test strip of claim 43 in which the opaque portions extend continuously in alignment with the opposed sides of the capillary channel from the perimetric edge surface to the electrodes.
0. 46. The test strip of claim 45 in which the opaque portions are sized and dimensioned such that the blood sample is required to fill up to the electrodes the portion of the capillary channel viewable through the viewing material and between the opaque portions in order to have a sufficient amount of blood sample to conduct a test.
0. 47. The test strip of claim 33 in which the viewing area includes only the capillary channel.
0. 48. The test strip of claim 43 in which the viewing area includes only the capillary channel.
|
wherein [Analyte] represents the concentration of the analyte in the sample (see
By making measurements with known concentrations of analyte, calibration curve 30 (
In a preferred method for analysis of glucose from a sample of human whole blood, current measurements are made at 0.5 second intervals from 3 seconds to 9 seconds after the potential difference is applied between the electrodes. These current measurements are correlated to the concentration of glucose in the blood sample.
In this example of measuring glucose from a blood sample, current measurements are made at different times (from 3 seconds to 9 seconds after application of the potential difference), rather than at a single fixed time (as described above), and the resulting algorithm is more complex and may be represented by the following equation:
[Glucose]=C1i1+C2i2+C3i3+ . . . Cnin+d,
wherein i1 is the current measured at the first measurement time (3 seconds after application of the 300 millivolt potential difference), i2 is the current measured at the second measurement time (3.5 seconds after application of the 300 millivolt potential difference), i3 is the current measured at the third measurement time (4 seconds after application of the 300 millivolt potential difference), in is the current measured at the nth measurement time (in this example, at the 13th measurement time or 9 seconds after application of the 300 millivolt potential difference), C1, C2, C3, and Cn are coefficients derived from a muiltivariate regression analysis technique, such as Principle Components Analysis or Partial Least Squares, and d is the regression intercept (in glucose concentration units).
Alternatively, the concentration of glucose in the sample being measured may be determined by integrating the curve generated by plotting current, i, versus measurement time over some time interval (for example, from 3 seconds to 9 seconds after application of the 300 millivolt potential difference), thereby obtaining the total charge transferred during the measurement period. The total charge transferred is directly proportional to the concentration of glucose in the sample being measured.
Further, the glucose concentration measurement may be corrected for differences between environmental temperature at the time of actual measurement and the environmental temperature at the time calibration was performed. For example, if the calibration curve for glucose measurement was constructed at an environmental temperature of 23° C., the glucose measurement is corrected by using the following equation:
[Glucose]corrected=[Glucose]measured×(1−K(T−23° C.)),
wherein T is the environmental temperature (in ° C.) at the time of the sample measurement and K is a constant derived from the following regression equation:
Y=K(T−23),
wherein
In order to calculate the value of K, each of a multiplicity of glucose concentrations is measured by the meter at various temperatures, T, and at 23° C. (the base case). Next, a linear regression of Y on T−23 is performed. The value of K is the slope of this regression.
Various features of the present invention may be incorporated into other electrochemical test strips, such as those disclosed in U.S. Pat. Nos. 5,120,420; 5,141,868; 5,437,999; 5,192,415; 5,264,103; and 5,575,895, the disclosures of which are hereby incorporated by reference.
Surridge, Nigel A., Crismore, William F., McMinn, Daniel R.
Patent | Priority | Assignee | Title |
11230727, | Oct 05 2016 | Roche Diabetes Care, Inc. | Detection reagents and electrode arrangements for multi-analyte diagnostic test elements, as well as methods of using the same |
Patent | Priority | Assignee | Title |
3838033, | |||
4224125, | Sep 28 1977 | Matsushita Electric Industrial Co., Ltd. | Enzyme electrode |
4254083, | Oct 25 1978 | CLINICAL DIAGNOSTIC SYSTEMS INC | Structural configuration for transport of a liquid drop through an ingress aperture |
4323536, | Feb 06 1980 | CLINICAL DIAGNOSTIC SYSTEMS INC | Multi-analyte test device |
4413407, | Oct 25 1978 | CLINICAL DIAGNOSTIC SYSTEMS INC | Method for forming an electrode-containing device with capillary transport between electrodes |
4432366, | Nov 27 1981 | SENTRON V O F , OOSTEINDE 8, 9301 LJ, RODEN, THE NETHERLANDS, A CORP OF NETHERLANDS | Reference electrode catheter |
4473457, | Mar 29 1982 | CLINICAL DIAGNOSTIC SYSTEMS INC | Liquid transport device providing diversion of capillary flow into a non-vented second zone |
4543326, | Nov 12 1981 | Wako Pure Chemical Industries, Ltd. | Stabilization of oxidase |
4654197, | Oct 18 1983 | MIGRATA U K LIMITED | Cuvette for sampling and analysis |
4684445, | Jul 05 1985 | Fuji Photo Film Co., Ltd. | Method and device of measuring ion activity |
4758323, | May 05 1983 | GENETICS INTERNATIONAL, INC | Assay systems using more than one enzyme |
4810633, | Jun 04 1984 | MILES INC | Enzymatic ethanol test |
4820399, | Aug 31 1984 | Shimadzu Corporation | Enzyme electrodes |
4830959, | Nov 11 1985 | MEDISENSE, INC | Electrochemical enzymic assay procedures |
4894137, | Sep 12 1986 | OMRON HEALTHCARE CO , LTD | Enzyme electrode |
4897173, | Jun 21 1985 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method for making the same |
4938860, | Jun 28 1985 | MILES INC | Electrode for electrochemical sensors |
4959305, | Jun 18 1986 | Miles Inc. | Reversible immobilization of assay reagents in a multizone test device |
4999582, | Dec 15 1989 | Roche Diabetes Care, Inc | Biosensor electrode excitation circuit |
4999632, | Dec 15 1989 | Roche Diabetes Care, Inc | Analog to digital conversion with noise reduction |
5006310, | Nov 03 1989 | Allergan, Inc | Schirmer tear test |
5120420, | Mar 31 1988 | MATSUSHITA ELECTRIC INDUSTRIAL CO , LTD | Biosensor and a process for preparation thereof |
5126034, | Jul 21 1989 | MEDISENSE, INC , CAMBRIDGE, MA A CORP OF MA | Bioelectrochemical electrodes |
5141868, | Feb 07 1986 | Inverness Medical Switzerland GmbH | Device for use in chemical test procedures |
5170799, | Feb 20 1988 | Showa Yakuhin Kako Co., Ltd. | Test strip for measuring tear production |
5192415, | Mar 04 1991 | MATSUSHITA ELECTRIC INSTRIAL CO , LTD | Biosensor utilizing enzyme and a method for producing the same |
5229299, | Apr 21 1992 | Hach Company | Test devices and methods for determining halides in aqueous samples |
5243516, | Dec 15 1989 | Roche Diabetes Care, Inc | Biosensing instrument and method |
5252293, | Jan 17 1989 | MOLECULAR DEVICES, INC | Analytical slide with porous filter membrane |
5264103, | Oct 18 1991 | Panasonic Corporation | Biosensor and a method for measuring a concentration of a substrate in a sample |
5288636, | Dec 15 1989 | Roche Diagnostics Corporation | Enzyme electrode system |
5304468, | Aug 13 1986 | LifeScan, Inc. | Reagent test strip and apparatus for determination of blood glucose |
5310525, | Feb 08 1990 | Whatman PLC | Fluid detection device |
5320732, | Jul 20 1990 | Matsushita Electric Industrial Co., Ltd. | Biosensor and measuring apparatus using the same |
5352351, | Jun 08 1993 | Roche Diabetes Care, Inc | Biosensing meter with fail/safe procedures to prevent erroneous indications |
5354447, | Dec 12 1991 | Kyoto Daiichi Kagaku Co., Ltd. | Biosensor and method of quantitative analysis using the same |
5366609, | Jun 08 1993 | Roche Diabetes Care, Inc | Biosensing meter with pluggable memory key |
5366902, | Oct 30 1990 | Hypoguard Limited | Collection and display device |
5385846, | Jun 03 1993 | Roche Diabetes Care, Inc | Biosensor and method for hematocrit determination |
5395504, | Feb 04 1993 | Asulab S.A. | Electrochemical measuring system with multizone sensors |
5405511, | Jun 08 1993 | Roche Diabetes Care, Inc | Biosensing meter with ambient temperature estimation method and system |
5407554, | May 10 1993 | Asulab S.A. | Electrochemical sensor with multiple zones on a disc and its application to the quantitative analysis of glucose |
5413690, | Jul 23 1993 | Roche Diabetes Care, Inc | Potentiometric biosensor and the method of its use |
5437999, | Feb 22 1994 | Roche Diabetes Care, Inc | Electrochemical sensor |
5438271, | Jun 08 1993 | Roche Diabetes Care, Inc | Biosensing meter which detects proper electrode engagement and distinguishes sample and check strips |
5502396, | Sep 21 1993 | Asulab S.A. | Measuring device with connection for a removable sensor |
5508171, | Dec 15 1989 | Roche Diabetes Care, Inc | Assay method with enzyme electrode system |
5547702, | Jul 08 1994 | Roche Diabetes Care, Inc | Method for continuous manufacture of diagnostic test strips |
5563042, | Aug 13 1986 | LifeScan, Inc. | Whole blood glucose test strip |
5575895, | Jun 02 1994 | PHC HOLDINGS CO , LTD ; PANASONIC HEALTHCARE HOLDINGS CO , LTD | Biosensor and method for producing the same |
5695949, | Apr 07 1995 | LXN CORP | Combined assay for current glucose level and intermediate or long-term glycemic control |
5728352, | Nov 14 1994 | PA Consulting Group | Disposable electronic diagnostic instrument |
5798031, | May 12 1997 | Bayer Corporation | Electrochemical biosensor |
5843691, | May 15 1993 | Lifescan, Inc | Visually-readable reagent test strip |
5985116, | Dec 24 1996 | PHC HOLDINGS CO , LTD ; PANASONIC HEALTHCARE HOLDINGS CO , LTD | Biosensor |
6027692, | Apr 07 1995 | LXN Corporation | Apparatus for combined assay for current glucose level and intermediate or long-term glycemic control |
6207000, | Apr 08 1998 | Roche Diagnostics GmbH | Process for the production of analytical devices |
6488827, | Mar 31 2000 | Cilag GmbH International; Lifescan IP Holdings, LLC | Capillary flow control in a medical diagnostic device |
6491803, | May 18 2001 | Apex Biotechnology Corporation | Test strip and biosensor incorporating with nanometer metal particles |
6531040, | Aug 02 1999 | Ascensia Diabetes Care Holdings AG | Electrochemical-sensor design |
CN1148016, | |||
EP10456, | |||
EP80304, | |||
EP127958, | |||
EP136362, | |||
EP170375, | |||
EP206218, | |||
EP230472, | |||
EP359831, | |||
EP400918, | |||
EP407800, | |||
EP537761, | |||
EP732406, | |||
GB2154003, | |||
GB2204408, | |||
JP1114746, | |||
JP1114747, | |||
JP1134244, | |||
JP1156658, | |||
JP5164756, | |||
JP60173457, | |||
JP60173458, | |||
JP60173459, | |||
JP6190050, | |||
JP63128252, | |||
JP63139246, | |||
JP63317757, | |||
JP63317758, | |||
JP6358149, | |||
JP6423153, | |||
WO8908713, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
May 01 1998 | HO, JIAXIONG JASON | Boehringer Mannheim Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020283 | /0128 | |
May 04 1998 | MCMINN, DANIEL R | Boehringer Mannheim Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020283 | /0128 | |
May 04 1998 | BODENSTEINER, RICHARD J | Boehringer Mannheim Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020283 | /0128 | |
May 04 1998 | CRISMORE, WILLIAM F | Boehringer Mannheim Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020283 | /0128 | |
May 06 1998 | BURKE, DAVID W | Boehringer Mannheim Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020283 | /0128 | |
May 08 1998 | DIEBOLD, ERIC R | Boehringer Mannheim Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020283 | /0128 | |
May 08 1998 | DELK, R DALE | Boehringer Mannheim Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020283 | /0128 | |
May 13 1998 | SURRIDGE, NIGEL A | Boehringer Mannheim Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020283 | /0128 | |
May 14 1998 | EARL, ROBERT KITCHEL | Boehringer Mannheim Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020283 | /0128 | |
May 14 1998 | HEALD, BRIAN A | Boehringer Mannheim Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020283 | /0128 | |
Dec 11 1998 | Boehringer Mannheim Corporation | Roche Diagnostics Corporation | MERGER SEE DOCUMENT FOR DETAILS | 020282 | /0499 | |
Dec 11 1998 | ROCHE DIAGNOSTIC SYSTEMS, INC | Roche Diagnostics Corporation | MERGER SEE DOCUMENT FOR DETAILS | 020283 | /0547 | |
Dec 31 1998 | ROCHE DIAGNOSTIC SYSTEMS, INC | Roche Diagnostics Corporation | MERGER SEE DOCUMENT FOR DETAILS | 020282 | /0499 | |
Oct 24 2003 | Roche Diagnostics Operations, Inc. | (assignment on the face of the patent) | / | |||
Oct 24 2003 | Roche Operations Ltd. | (assignment on the face of the patent) | / | |||
Jan 01 2004 | Roche Diagnostics Corporation | Roche Diagnostics Operations, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 015201 | /0368 | |
Jun 11 2007 | Roche Diagnostics Operations, Inc | Corange International Limited | ASSIGNOR HEREBY CONFIRMS THE ASSIGNMENT TO CORANGE INTERNATIONAL LIMITED OF AN UNDIVIDED ONE-HALF INTEREST IN EACH OF THE APPLICATIONS | 019419 | /0381 | |
Jul 15 2008 | Corange International Limited | ROCHE OPERATIONS LTD | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 022634 | /0371 | |
Mar 02 2015 | Roche Diagnostics Operations, Inc | Roche Diabetes Care, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 036008 | /0670 |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Jul 19 2014 | 4 years fee payment window open |
Jan 19 2015 | 6 months grace period start (w surcharge) |
Jul 19 2015 | patent expiry (for year 4) |
Jul 19 2017 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jul 19 2018 | 8 years fee payment window open |
Jan 19 2019 | 6 months grace period start (w surcharge) |
Jul 19 2019 | patent expiry (for year 8) |
Jul 19 2021 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jul 19 2022 | 12 years fee payment window open |
Jan 19 2023 | 6 months grace period start (w surcharge) |
Jul 19 2023 | patent expiry (for year 12) |
Jul 19 2025 | 2 years to revive unintentionally abandoned end. (for year 12) |